Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis
Clinical trial NCT06109818 · COMPLETED
Trial details
- NCT number
- NCT06109818
- Sponsor
- Beijing InnoCare Pharma Tech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-04
- Primary completion
- 2024-08-05
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.